Press Releases

Mar 25, 2026

Leila Farooq

Press Releases

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Beam Therapeutics announced updated clinical data from its ongoing Phase 1/2 trial of BEAM-302, a gene-editing therapy for Alpha-1 Antitrypsin Deficiency (AATD). The therapy showed a well-tolerated safety profile and durable increases in functional AAT protein with significant reduction in mutant Z-AAT after a single dose. Beam selected 60 mg as th…

BEAM

Mar 25, 2026

Hana Yamamoto

Press Releases

Winnebago Industries Reports Second Quarter Fiscal 2026 Results

Winnebago Industries, a leading manufacturer in outdoor recreation products, reported a 6% increase in net revenues to $657.4 million for Q2 Fiscal 2026 and significant profitability improvements, including a 42.1% rise in adjusted earnings per diluted share to $0.27. The company improved operating income by 50.7% to $11.8 million and executed a $1…

WGO

Mar 25, 2026

Nina Shah

Press Releases

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck & Co., Inc. announced an agreement to acquire Terns Pharmaceuticals, a clinical-stage oncology company, for approximately $6.7 billion. The acquisition focuses on Terns' lead investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor, TERN-701, which is in Phase 1/2 trials for chronic myeloid leukemia (CML). The deal reflects Merck's…

MRK TERN

Mar 25, 2026

Avery Klein

Press Releases

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

Kanzhun Limited, operating as BOSS Zhipin, announced the continuation and expansion of its share repurchase program, having spent nearly RMB450 million in 2026 to buy back shares. The board increased repurchase authorization to US$400 million through August 2027 and committed to allocating at least 50% of adjusted net income annually for dividends …

BZ

Mar 25, 2026

Maya Rios

Press Releases

PDD Holdings Announces Fourth Quarter 2025 and Fiscal Year 2025 Unaudited Financial Results

PDD Holdings Inc., a US-listed e-commerce company on NASDAQ, announced its unaudited financial results for Q4 and the fiscal year 2025. The company reported a 12% revenue increase in Q4 and a 10% increase for the full year, driven by growth in online marketing and transaction services. However, net income declined by about 11%-12% due to higher ope…

PDD

Mar 25, 2026

Maya Rios

Press Releases

NOV Announces Expansion of Subsea Flexible Pipe Manufacturing Capacity to Support Growing Demand

NOV Inc. announced a $200 million investment to roughly double the capacity of its subsea flexible pipe manufacturing facility in Açu, Brazil, over three years. The expansion aims to satisfy strong demand driven by offshore development activity and replacement needs, with capacity currently near full utilization and backlog extending through 2028. …

NOV

Mar 25, 2026

Ajmal Hussain

Press Releases

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics, a U.S.-based biopharmaceutical company specializing in plasma-derived biologics for immune deficiencies, has publicly addressed a negative short-seller report issued by Culper Research. The company refutes the report's assertions as speculative and false, emphasizing its compliance with regulatory standards and ongoing review of the…

ADMA

Mar 25, 2026

Maya Rios

Press Releases

Amaze Highlights First Quarter 2026 Achievements and Upcoming Priorities in Letter to Shareholders

Amaze Holdings, Inc. issued a shareholder letter highlighting its transition from stabilizing the business in 2025 to accelerating growth in 2026. The company is focusing on expanding its Creator Commerce Flywheel by leveraging proprietary data, enhancing distribution through partnerships like the LA Times Studios integration, and scaling modular i…

AMZE

Mar 25, 2026

Avery Klein

Press Releases

Akamai Launches Brand Guardian to Help Enterprises Combat Automated Fraud

Akamai Technologies has introduced Brand Guardian, an AI-driven solution designed to help enterprises proactively detect and manage brand impersonation and fraudulent digital content. By combining continuous internet monitoring with automated takedowns at 99.99% accuracy, it aims to protect sectors like financial services, retail, and healthcare fr…

AKAM

Mar 25, 2026

Hana Yamamoto

Press Releases

Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026

Comstock Inc. announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit scheduled for April 1, 2026. The company continues to focus on innovative technologies that extract and recycle critical metals from end-of-life photovoltaics, supporting clean energy systems.

LODE

Mar 25, 2026

Hana Yamamoto

Press Releases

Viomi Technology Co., Ltd Reports Second Half and Full Year 2025 Unaudited Financial Results and Announces Special Dividend

Viomi Technology Co., Ltd, a NASDAQ-listed Chinese home water solutions company, announced unaudited financial results for H2 and full-year 2025, showing a 14.6% revenue increase to RMB2.43 billion for the year despite a 25.9% revenue decline in the second half. Net income dipped slightly by 1.9% year-over-year to RMB141.6 million. The company attr…

VIOT

Mar 25, 2026

Derek Hwang

Press Releases

RSA Conference 2026: Varonis CEO Yaki Faitelson to Deliver Keynote on Securing the Agentic AI Revolution

Varonis Systems, Inc. announced that CEO Yaki Faitelson will deliver the keynote speech at RSA Conference 2026 focusing on AI's impact on enterprise security. The company will showcase its new Atlas AI security platform, emphasizing tools to secure AI and data at scale, aiming to help organizations future-proof AI and data security programs.

VRNS

Mar 25, 2026

Nina Shah

Press Releases

VEON Highlights Uklon’s Expansion into Travel, Strengthening its Mobility Ecosystem in Ukraine

VEON Ltd., a Nasdaq-listed digital operator, announced that its subsidiary Uklon, Ukraine’s leading ride-hailing service, has launched a new Travel service within its app. This service allows users to book domestic and international bus tickets, expanding Uklon's offerings beyond urban ride-hailing and delivery into intercity and cross-border mobil…

VEON

Mar 25, 2026

Hana Yamamoto

Press Releases

Auddia Announces LT350 Micro Warehouse Network in Parking Lots for Last Mile Delivery

Auddia Inc. announced the development of the LT350 micro warehouse network, a patented platform transforming parking lots into distributed logistics hubs integrating drones, autonomous electric vehicles, secure package lockers, and AI-driven routing. This platform aims to address last-mile delivery challenges by creating a solar-powered canopy infr…

AUUD

Mar 25, 2026

Sofia Navarro

Press Releases

Kyivstar Subsidiary Uklon Expands Product Ecosystem with Bus Ticket Purchasing

Kyivstar Group's subsidiary Uklon, Ukraine's largest ride-hailing company, has launched a new "Travel" service within its app, enabling users to buy domestic and international bus tickets directly without third-party platforms. This expansion diversifies Uklon's offerings beyond ride-hailing into a broader mobility and travel ecosystem. Kyivstar, l…

KYIV

Mar 25, 2026

Hana Yamamoto

Press Releases

Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

Zhihu Inc. announced its unaudited financial results for Q4 and fiscal year 2025, reporting a decline in total revenues for both the quarter and full year compared to 2024, with a Q4 net loss of RMB210.8 million (US$30.1 million). Despite revenue decreases driven by a strategic refinement of service offerings and membership declines, the company ac…

ZH

Mar 25, 2026

Hana Yamamoto

Press Releases

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

Royal Philips has launched IntraSight Plus, an integrated interventional cardiology platform cleared by the FDA and CE marked for Europe. The system combines diagnostic imaging and physiology tools on a single screen, streamlining workflow, improving precision in treatment planning, and potentially reducing operation times by up to 47%. The launch …

PHG

Mar 25, 2026

Leila Farooq

Press Releases

Diversified Files Definitive Proxy Materials

Diversified Energy Company has filed its Definitive Proxy Statement and additional proxy materials with the SEC for its 2026 Annual Meeting scheduled for May 6, 2026. The company is utilizing SEC rules for electronic access to proxy materials and has notified shareholders on how to participate virtually. Diversified Energy emphasizes its strategy o…

DEC

Mar 25, 2026

Caleb Monroe

Press Releases

Yimutian Inc. Announces Resignation of Independent Director

Yimutian Inc., a leading agricultural B2B platform in China listed on NASDAQ, announced the resignation of independent director Junchen Sun for personal reasons. The company is actively seeking a replacement, with oversight from its Nominating and Corporate Governance Committee, and will disclose updates as required by SEC and NASDAQ regulations.

YMT

Mar 24, 2026

Avery Klein

Press Releases

Rogers Communications Inc. Announces Pricing of Public Offering of US$750 million Fixed-to-Fixed Rate Subordinated Notes and Canadian Private Placement of Cdn$1.25 billion Fixed-to-Fixed Rate Subordinated Notes

Rogers Communications Inc. announced the pricing of a US$750 million public offering of fixed-to-fixed rate subordinated notes due 2056 in the U.S. and a C$1.25 billion private placement of similar notes in Canada. The net proceeds will be used to repay outstanding debt. Closings are expected on March 27, 2026.

RCI

Mar 24, 2026

Derek Hwang

Press Releases

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

Apogee Therapeutics, a clinical-stage biotech company specializing in novel biologics for inflammatory and immunology markets, has priced a $350 million underwritten public offering of 5 million shares at $70 each. The offering aims to strengthen the company's financial position to advance its pipeline, including its lead candidate Zumilokibart tar…

APGE

Mar 24, 2026

Maya Rios

Press Releases

Comstock Announces Full Year 2025 Achievements and Results

Comstock Inc. announced its full year 2025 financial results, key achievements including final proof of zero-landfill recycling process, secured permits for industry-scale solar panel recycling facilities in Nevada, and the successful capitalization with $57.5 million equity financing. The company separated its renewable fuels business, Bioleum Cor…

LODE

Mar 24, 2026

Caleb Monroe

Press Releases

Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026

Solana Company, a NASDAQ-listed neurotechnology and digital asset treasury firm, will announce its fourth quarter and full year 2025 operating results on March 30, 2026, followed by a management conference call. The company combines medical device innovation with a digital asset treasury focused on holding Solana (SOL), aiming to leverage both sect…

HSDT

Mar 24, 2026

Leila Farooq

Press Releases

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results

PDS Biotechnology Corporation announced a conference call and webcast for March 30, 2026, to report its fourth quarter and full-year 2025 financial results. The company will also provide updates on its pivotal clinical trials, including its lead immunotherapy program targeting HPV16-positive head and neck cancers using PDS0101 in combination therap…

PDSB

Mar 24, 2026

Priya Menon

Press Releases

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Absci Corporation reported its Q4 and full year 2025 results, highlighting successful dosing in the SAD portion of its ABS-201 Phase 1/2a trial for androgenetic alopecia with favorable safety data. The company unveiled ex vivo data showing ABS-201 stimulates hair growth and regenerates follicle stem cell niches. Absci appointed Dr. Ransi Somaratne …

ABSI